EXOTIC BIRD BREEDING BUSINESS PLAN
I. Executive Summary
Company Description
Aerolark Avian Farms (name origin: "Aero" for air, "lark" for bird) is a U.S.-based avian operator launching operations in Q2 2026. We operate at the intersection of exotic companion birds and gourmet poultry, running a high-tech breeding aviary combined with a sustainable farm. Our primary offerings are hand-raised exotic companion birds with full provenance documentation and premium heritage poultry products for upscale restaurants and specialty retailers. We emphasize animal welfare, strict biosecurity, and genetic management as core operating principles that underpin product quality and traceability.
Day-to-day activities include controlled-environment breeding, genetic selection, veterinary care, on-site hatchery operations, sustainable pasture management, cold-chain processing for culinary clients, and owner onboarding for companion birds. We target high-income pet buyers and Michelin-level kitchens in the Northeast and West Coast markets. Short-term goals: achieve regulatory compliance, complete facility commissioning by June 2026, and onboard first 50 companion-bird customers and 5 restaurant partners in year one. Long-term goals: expand to two regional facilities by 2030 and reach $6M ARR while maintaining certified welfare and biosecurity standards.
Problem
U.S. buyers and chefs lack a reliable source that serves both exotic companion birds and gourmet poultry. Owners face high mortality and poor socialization because breeding is often unmonitored and hand-rearing is scarce. Professional chefs face inconsistent supply and no reliable welfare traceability, which prevents menu guarantees and consistent sourcing. The market gap is a missing dual-purpose operator that provides lifetime companion support plus farm-to-table transparency; opaque supply chains, high mortality rates, and lack of specialized hand-rearing are the core failures driving customer pain.
One-liner: Launching in 2026, our facility addresses these unmet needs for high-income owners and the upscale culinary market by delivering consistent supply, verifiable welfare, and specialized hand-rearing under strict biosecurity and genetic management.
Solution
The market lacks a reliable source of well‑socialized, health‑guaranteed exotic birds and traceable, high‑welfare poultry. We operate a U.S. biosecure facility with two physically separate divisions that deliver well‑socialized companion macaws and parrots and USDA‑compliant premium poultry, closing that gap for owners, avian vets, specialty retailers, and epicurean buyers.
Companion birds are hand‑raised under intensive socialization protocols with advanced incubation to improve hatch viability and health. The gourmet poultry line uses sustainable grow‑out practices and USDA‑compliant processing. Separate housing and protocols prevent cross‑contamination and protect animal welfare and buyer traceability.
Mission Statement
We set the gold standard in avian husbandry by raising ethically raised, well-socialized companion birds and producing premium gourmet poultry through transparent, traceable operations and strict welfare protocols. We prioritize measurable bird welfare, customer education, and food-safety practices to deliver healthy, behaviorally sound birds and chef-grade products. We commit to continuous improvement, open reporting, and partnerships with veterinarians and regulators to build trust with owners, buyers, and communities.
Key Success Factors
Our financial returns, mortality improvements, retention, infrastructure, and management drive viability.
-
Return on Equity 19.1% sustaining investor returns and growth capital.
-
5-month breakeven with a 48-month payback ensures quick recovery of cash outflows.
-
20.0% juvenile retention for breeding secures inventory and genetic program strength.
-
Mortality reduced to 2.3% by 2035 improving yield and lowering variable costs.
-
$1.57M biosecure infrastructure plus experienced leadership: GM $100,000 and Lead Aviculturist $70,000.
Financial Summary
Summary: first-year EBITDA is $33,000, scaling to $3,783,000 by 2035; key project metrics are shown below.
Ratio | 2026 | 2027 | 2028 |
Projected Revenue | Not provided | Not provided | Not provided |
Projected EBITDA | $33,000 | $544,000 | $862,000 |
Expected ROI | IRR 4.0% | IRR 4.0% | IRR 4.0% |
Financial requirements: total confirmed capex is $1,530,000 and the minimum cash shortfall observed is $556,000 (Dec-26); anticipated returns are IRR 4.0%, ROE 19.1%, and payback in 48 months.
Outlook: the model shows scalable EBITDA growth and positive ROE with a moderate IRR, requiring $1.53M capex plus a $556K cash bridge.
Funding Requirements
We seek external capital to build biosecure facilities, acquire breeding pairs, set up incubation and veterinary capacity, and fund initial operations and marketing—total required: $2,126,000.
Categories | Amount, USD |
Product Development (IT systems) | $30,000 |
Marketing (initial) | $0 (included in CAPEX) |
Operations (facility build & equipment) | $1,570,000 |
Staffing (initial payroll) | $0 (funded from working capital) |
Transport & Vehicles | $50,000 |
Feed storage & security | $60,000 |
Incubation & veterinary setup | $140,000 |
Working capital | $556,000 |
Total funding required | $2,126,000 |
Financial snapshot: Year‑1 EBITDA $33,000; 2035 EBITDA $3,780,000; breeding flock grows 10 → 55 females; staff scales to 15.0 FTEs; COGS 13.0%; marketing steady at 3.0% of revenue; IRR 4.0% with strong ROE.